Reducing the 40% insertion failure rate of cannulation, the most common invasive procedure.
Since the advent of intravenous cannulas in the 1950’s, clinicians have used subjective judgement through visual examination and manual palpation to estimate the location and quality of veins to target with a needle for cannulation. 70 years on, the average insertion failure rate is 40%, and up to 70% in individuals with difficult intravenous access (DIVAs) such as children, chemotherapy and obese patients. Given 1 billion cannulas are placed yearly, these unnecessary failures result in pain and stress for both patients and clinicians, increasing the risk of complications and delaying care.
fail on first
VeinWise is a handheld ultraportable unit designed to assist with visualising veins to target for cannulation. It is designed to minimize training requirements and cost, therefore allowing for widespread adoption.
VeinWise aims to significantly reduce the first-pass failure rate of 40%. By finding the right veins faster, we envision better patient satisfaction, lower risks of complications and improved clinical efficiency.
With a global increasing trend of chronic disease and obesity, the failure rate continues to grow, representing a significant market opportunity for VeinTech and the VeinWise technology.